CID HoldCo, Inc. (DAIC) Key Metrics
DAIC valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.8M
- Enterprise value
- $5.3M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.7
- Price / book
- 20.7
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.34
DAIC key metrics, 2021–2025
Fiscal year ended December 31, 2025 · U.S. dollarsDAIC valuation Price multiples at each fiscal year-end price.
DAIC returns How much profit the business earns on the capital it uses.
DAIC per-share figures Results divided by the shares outstanding at year-end.
DAIC financial health Debt, liquidity and how easily interest is covered.
DAIC efficiency & capital use Working capital cycle and where the cash goes.
DAIC valuation history
DAIC returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
DAIC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
DAIC cash returned to shareholders
DAIC price vs earnings per share
DAIC key metrics
2021–2025| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Valuation | |||||
| Market capitalization | $9.3M | $1.17B | — | $253.2M | — |
| Enterprise value | $10.6M | $1.17B | — | $252.4M | — |
| Price / sales | 1.6 | — | — | 427.9 | — |
| Price / book | 38.6 | — | — | — | — |
| EV / sales | 1.8 | — | — | 426.5 | — |
| Earnings yield | −396.6% | −0.2% | — | −0.4% | — |
| Free cash flow yield | −150.4% | −0.1% | — | −0.4% | — |
| Shareholder yield (dividends + buybacks) | 54.0% | 1.4% | — | 0.0% | — |
| Share price at fiscal year-end | $11.22 | $270.00 | — | $255.00 | — |
| Per share | |||||
| Revenue per share | $7.03 | $0.04 | $0.44 | $0.60 | $0.00 |
| Earnings per share | −$44.50 | −$0.47 | −$1.95 | −$0.97 | −$0.13 |
| Operating cash flow per share | −$16.07 | −$0.19 | −$1.68 | −$0.88 | −$0.35 |
| Free cash flow per share | −$16.88 | −$0.19 | −$2.36 | −$1.14 | −$0.35 |
| Cash per share | $1.05 | $0.10 | $0.61 | $0.83 | $0.47 |
| Book value per share | $0.29 | −$1.89 | −$2.97 | −$1.08 | $177.20 |
| Tangible book value per share | −$3.25 | −$2.30 | −$3.91 | −$1.34 | $177.20 |
| Capex per share | $0.81 | $0.00 | $0.68 | $0.26 | $0.00 |
| Debt per share | $2.74 | $0.14 | — | — | — |
| Shares outstanding | 825K | 4.3M | 993K | 993K | 1.7M |
| Change in shares outstanding | −80.9% | +335.8% | 0.0% | −40.6% | — |
| Returns & profitability | |||||
| Return on equity (ROE) | — | — | — | — | −0.1% |
| Return on invested capital (ROIC) | — | — | — | — | −0.1% |
| Return on assets (ROA) | −423.9% | −49.0% | −134.3% | −0.6% | −0.1% |
| Return on tangible assets | −471.9% | −41.9% | −253.1% | −103.0% | −0.1% |
| Free cash flow margin | −240.0% | −475.5% | −532.4% | −191.3% | — |
| Financial health | |||||
| Total debt | $2.3M | $600,000 | — | — | — |
| Cash & short-term investments | $865,624 | $432,533 | $605,760 | $826,582 | $790,770 |
| Net debt | $1.4M | $167,467 | −$605,760 | −$826,582 | −$790,770 |
| Debt / equity | 9.43 | — | — | — | — |
| Debt / assets | 0.21 | 0.09 | — | — | — |
| Current ratio | 0.79 | 0.07 | 17.38 | 18.64 | 2.93 |
| Quick ratio | 0.61 | 0.06 | 17.38 | 18.64 | 2.93 |
| Interest coverage | -22.9 | -4.1 | — | -95.5 | — |
| Working capital | −$1.7M | −$5.5M | $722,276 | $889,456 | $871,811 |
| Invested capital | $1.6M | −$8.0M | −$3.6M | −$1.9M | $295.5M |
| Tangible asset value | −$2.7M | −$10.0M | −$3.9M | −$1.3M | $296.3M |
| Net current asset value | −$4.1M | −$14.4M | −$3.9M | −$1.3M | −$10.3M |
| Graham net-net per share | −$7.47 | −$3.31 | −$4.07 | −$1.37 | −$6.50 |
| Capital allocation | |||||
| Share buybacks (net) | $5.0M | $16.0M | $292.5M | $26,775 | — |
| Capex / revenue | 11.6% | 0.0% | 152.9% | 43.1% | — |
| Capex / depreciation | 18.39 | 0.00 | — | — | — |
| Stock-based compensation / revenue | 0.7% | 114.1% | 14.1% | 6.0% | — |
| R&D / revenue | 24.9% | 440.1% | 190.5% | 120.4% | — |
| SG&A / revenue | 179.9% | 2,078.4% | 271.1% | 96.6% | — |
| Efficiency | |||||
| Days sales outstanding | 115.6 | 58.2 | 48.8 | 69.6 | — |
| Days of inventory on hand | 86.1 | 545.8 | — | — | — |
| Days payables outstanding | 281.9 | 3,228.9 | 29.8 | 30.6 | — |
| Cash conversion cycle (days) | -80.1 | -2,625.0 | 19.0 | 39.0 | — |
| Receivables turnover | 3.16 | 6.27 | 7.48 | 5.25 | — |
| Payables turnover | 1.29 | 0.11 | 12.26 | 11.94 | — |
| Inventory turnover | 4.24 | 0.67 | — | — | — |
| Asset turnover | 0.67 | 0.04 | 0.30 | 0.00 | 0.00 |
| Average receivables | $1.8M | $27,521 | $58,782 | $112,786 | — |
| Average payables | $2.4M | $386,005 | $7,088 | $12,441 | — |
| Average inventory | $748,064 | $65,248 | — | — | — |
| Intangibles / total assets | 27.3% | 26.6% | 54.7% | 21.3% | 0.0% |
Computed from DAIC's annual financial statements (latest annual report filed March 11, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
DAIC valuation and financial ratios
It ended the year with $2.3 million of debt and $0.9 million in cash and short-term investments, net debt of $1.4 million. It returned $5.0 million to shareholders: $0 in dividends and $5.0 million in share buybacks. The share count fell 50.7% from 1.7M to 825K over 4 years.
See the DAIC income statement, the DAIC chart for price history, or the DAIC stock overview for the latest quote and news.
DAIC key metrics FAQ
How much debt does CID HoldCo have?
CID HoldCo had total debt of $2.3 million at the end of fiscal 2025, a debt-to-equity ratio of 9.43.
Does CID HoldCo buy back its shares?
Yes. CID HoldCo spent $5.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −80.9% over the year, to 825K..
What is CID HoldCo's free cash flow yield?
CID HoldCo generated -$13.9 million of free cash flow in fiscal 2025, a free cash flow yield of −150.4% on its market value at year-end ($9.3 million).
What is CID HoldCo's current ratio?
CID HoldCo's current ratio was 0.79 at the end of fiscal 2025: current assets were 0.79 times current liabilities.